EGRX - Eagle Pharmaceuticals Stock Trading

Eagle Pharmaceuticals Inc.(NASDAQ: EGRX) stock trading, description, contact, officers and directors.

About Eagle Pharmaceuticals Inc.

Not available

Stock Information

Eagle Pharmaceuticals Inc. Company Name:

EGRX Stock Symbol:

NASDAQ Market:

Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...

EGRX - Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that its Board of Directors has approved a $25 million accelerated share repurchase (“ASR”) transaction with JPMorgan Chase Bank, National Association (“...
EGRX - Eagle Pharmaceuticals' Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021

- Eagle to receive $5 million milestone payment - - RTD and Rapid Infusion (“RI”) formulations could generate $10 million - $25 million annually for Eagle - Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today ...
EGRX - Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences

Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming conferences in September. At the Morgan Stanley 18 th Annu...